Received: 12 August 2019
Accepted: 24 December 2019
First Online: 2 January 2020
Ethics approval and consent to participate
: Ethical clearance and approval was obtained from Tigray Health Research Institute (THRI) Institutional Review Board (IRB) / Ethical Review Committee with the reference no of THRI/00132/19. Permission to use the data was obtained from the Tigray Regional Health Bureau and THRI. The data were from a secondary database on HIV infected patients for VL monitoring while on combination of antiretroviral treatment. The data were not accessible by any other third party other than the study team. All data was anonymised and informed consent was waived from the ethics committee.
: Not applicable.
: Authors’ declare that there are no competing interests.